Rice web server helps identify COVID-19 drug candidates
Rice University researchers have introduced an online portal to help researchers screen COVID-19 drug candidates that might attack specific proteins of the SARS-CoV-2 virus. Lydia…
Category Research
Read More
Horse hyperimmune antibody may help the fight against COVID-19
A study conducted by a consortium of Brazilian researchers has demonstrated that a hyperimmune serum consisting of purified antibody fragments produced in horses may be…
One coronavirus vaccine may protect against other coronaviruse
Northwestern Medicine scientists have shown for the first time that coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses. The…
mRNA COVID vaccines highly effective at preventing symptomatic infection in health workers
COVID-19 vaccines are highly effective in preventing symptomatic illness among health care workers in real-world settings. The study, published in the New England Journal of…
How to develop new drugs based on merged datasets
Polymorphs are molecules that have different molecular packing arrangements despite identical chemical compositions. In a recent paper, researchers at GlaxoSmithKline (GSK) and the Cambridge Crystallographic…
COVID-19 nasal vaccine candidate effective at preventing disease transmission
Breathe in, exhale . That’s how easy it’s for SARS-CoV-2, the virus that causes COVID-19, to enter your nose. And though remarkable progress has been…
How a plant virus could protect and save your lungs from metastatic cancer
Using a virus that grows in black-eyed pea plants, nanoengineers at the University of California San Diego developed a replacement treatment that would keep metastatic…
Scientific evidence to date on COVID-19 vaccine efficacy does not support boosters for general population
An expert review by a world group of scientists, including some at the WHO and FDA, concludes that, even for the delta variant, vaccine efficacy…
Blood vessels produce protein that promotes metastases
Blood vessels supply tumors with nutrients and, on the opposite hand, enable cancer cells to spread throughout the body. The settlement of circulating tumor cells…
Bayer extends clinical development program for finerenone with Phase III study in patients with non-diabetic chronic kidney disease
There are limited treatment options available for chronic renal disorder (CKD), and patients often still reach renal failure or premature death / The phase III…
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) together With Chemotherapy surely Patients With Locally Recurrent Unresectable or Metastatic Triple-Negative carcinoma Whose Tumors Express PD-L1 (CPS ≥10)
Recommendation supported Data From Phase 3 KEYNOTE-355 Trial Merck, referred to as MSD outside the us and Canada, today announced the Committee for Medicinal Products…
Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin’s Lymphoma (B-NHL) Published within the Lancet
Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin’s Lymphoma (B-NHL) Published within the Lancet AbbVie (NYSE: ABBV) and Genmab A/S (Nasdaq:…